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Honeybees produce honey, royal jelly, propolis, bee venom, bee pollen, and
beeswax, which potentially benefit to humans due to the bioactives in them. Clinical
standardization of these products is hindered by chemical variability depending
on honeybee and botanical sources, but different molecules have been isolated
and pharmacologically characterized. Major honey bioactives include phenolics,
methylglyoxal, royal jelly proteins (MRJPs), and oligosaccharides. In royal jelly there
are antimicrobial jelleins and royalisin peptides, MRJPs, and hydroxy-decenoic acid
derivatives, notably 10-hydroxy-2-decenoic acid (10-HDA), with antimicrobial, anti-
inflammatory, immunomodulatory, neuromodulatory, metabolic syndrome preventing,
and anti-aging activities. Propolis contains caffeic acid phenethyl ester and artepillin
C, specific of Brazilian propolis, with antiviral, immunomodulatory, anti-inflammatory
and anticancer effects. Bee venom consists of toxic peptides like pain-inducing
melittin, SK channel blocking apamin, and allergenic phospholipase A2. Bee pollen
is vitaminic, contains antioxidant and anti-inflammatory plant phenolics, as well as
antiatherosclerotic, antidiabetic, and hypoglycemic flavonoids, unsaturated fatty acids,
and sterols. Beeswax is widely used in cosmetics and makeup. Given the importance of
drug discovery from natural sources, this review is aimed at providing an exhaustive
screening of the bioactive compounds detected in honeybee products and of their
curative or adverse biological effects.
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INTRODUCTION
Honeybees are social hymenopteran insects belonging to the genus Apis, characterized by the
production and storage of honey and other substances potentially useful to humans. Two
domesticated species are currently known, i.e., the western A. mellifera, native to Europe, Asia
and Africa, and introduced into America, and the eastern A. cerana, distributed in southern and
southeastern Asia.
Honey is the main and most widely appreciated honeybee product. It derives from digestive
processing of nectar foraged from flowers, and is stored in honeycomb cells. Honey is generally
marketed for its nutritive properties, but has been also used since the antiquity as a folk remedy,
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while in recent times it has been introduced as a pharmaceutical
aid and in clinical practice (Molan, 1999). Other products derive
from honeybee gland secretions and different botanical materials,
either alone or variously mixed together. These substances
include royal jelly, beeswax, propolis, bee pollen, and bee venom.
All of them have been used by humans since ancient times for
nutritional and curative purposes.
Several biological properties have been detected in honeybee
products by a wide series of scientific studies, while different
reviews have been dedicated to summarize therapeutic properties
and uses as nutraceutical, pharmaceutical and cosmetic
ingredients (Viuda-Martos et al., 2008; Burlando and Cornara,
2013). Various attempts at introducing some of these products
in clinical settings have been made, but their pharmacological
and medicinal standardization is made difficult by the high
chemical variability, depending on honeybee varieties and
botanical sources. However, different molecules or classes of
compounds have been isolated and some of them have also been
pharmacologically characterized, suggesting the importance of
honeybee products for drug discovery from natural sources.
Given the importance of this latter field in the search for new
remedies against problematic diseases, this review is aimed to
provide an exhaustive screening of the bioactive compounds
detected in honeybee products and of their curative or adverse
biological effects. Literature data were collected in Scopus, Web
of Science, PubMed, Google Scholar, https://clinicaltrials.gov,
and Espacenet databases. General medicinal application of
honeybee products has been covered, while more in depth
search on bioactivities and putative therapeutic effects has been
conducted on the major constituents of these products.
HONEY
Honey is produced by foraging bees that collect flower nectar
and process it through repeated digestion and regurgitation.
Stomach acidic pH, together with invertase, diastase and amylase
enzymatic activities, give rise to a supersaturated aqueous
solution composed by 80% sugars, mainly fructose and glucose,
with minor amounts of sucrose, maltose, and other complex
sugars.
Most nitrogen is present in amino acids and peptides. Proline
is the most abundant amino acid, followed by glutamic acid,
alanine, phenylalanine, tyrosine, leucine, isoleucine, and other
minor ones. Honey also contains low amounts of protein,
usually 0.1÷1.5% in the western honeybee A. mellifera, and
0.1÷3.0% in the Asiatic honeybee A. cerana. Most abundant
peptides are defensin-1 and royal jelly protein (MRJP) isoforms,
while major enzymes include glucose oxidase, diastase (amylase),
α-glucosidase, catalase, and acid phosphatase (Kubota et al., 2004;
Di Girolamo et al., 2012; Chua et al., 2015). Data about honey
proteome are limited, but it is arguable that each honey type has
its own peptide pattern, consisting of ubiquitous components
and a variable set of minor elements, possibly including plant
peptides.
Honey has an average pH of 3.9, mainly due to the presence
of about 0.57% organic acids, predominantly gluconic acid
originating from glucose oxidase activity, and citric acid. Small
amounts of vitamins are also present, especially vitamin B
complex due to pollen grains, and ascorbic acid. Minerals range
between 0.04 and 0.2%, reflecting the mineral content of soils
where source plants grow. Potassium is the major element,
accounting for about one third of total mineral content.
Different plant compounds are present in honey at low
concentrations and in variable amounts depending on the
botanical species visited by bees and the climate of the area from
which nectar is harvested. Aroma compounds are probably the
most diversified fraction, as testified by the finding of over 500
volatile compounds in different types of honey. Phenolics are
the most abundant phytochemicals, usually ranging from 50 to
500 mg/kg (Ramanauskiene et al., 2012; da Silva et al., 2016).
Antioxidant Activity
It is generally accepted that phenolics are important contributors
to the antioxidant capacity of honey. Given that phenolic
composition is greatly variable with respect to floral origin, honey
is expected to show a wide range of antioxidant power (Gheldof
et al., 2002; Petretto et al., 2015).
Antimicrobial Activity
Honey is known to contrast the growth of various
microorganisms. This kind of effect has been a main attractive
feature for honey application in clinical medicine, as testified by
the development and marketing of γ-irradiated, Manuka medical
grade honey. For this honey, a scale of antibacterial activity
has been defined, known as Unique Manuka Factor (UMF),
representing equivalents of a phenol solution yielding a certain
inhibition in a radial diffusion assay on Staphylococcus aureus
(Allen et al., 1991).
The role of specific honey antibacterial factors has been
studied by sequential neutralization, showing that the
mechanisms of action are complex and variable in different
honey types. Basic antibacterial factors are low water activity
and low pH. In addition, honey generally contains glucose
oxidase added by bees, which by low dilution converts glucose
into H2O2 and gluconic acid. However, measurements of
minimum inhibitory concentration and DNA degradation on
Escherichia coli and Bacillus subtilis has shown that honey H2O2
concentrations would not fully account for bacterial growth
inhibition, suggesting that other honey components should be
involved (Brudzynski et al., 2011). Two major non-peroxide
antibacterial factors are methylglyoxal (MGO) in manuka
honey and defensin-1 in Revamil source (RS) honey, which also
contains MGO, but to a much lower extent than manuka honey.
RS honey is the source product for Revamil R© medical grade
honey (Kwakman and Zaat, 2012).
Manuka honey derives from the nectar of the manuka
myrtle Leptospermum scoparium, growing in southeast Australia
and New Zealand. In this honey, high amounts of MGO
are formed from dihydroxyacetone, present at high levels in
manuka nectar, through a non-enzymatic process occurring
during honey storage. The very high content of MGO, up to
about 1,500 mg/kg, makes this honey able to kill various bacterial
strains, including methicillin-resistant S. aureus (Mavric et al.,
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2008). However, other unidentified compounds besides MGO
are likely to contribute to antibacterial activity, since it has been
experimentally shown that MGO neutralization affects honey
activity against S. aureus and B. subtilis, but not against E. coli
and Pseudomonas aeruginosa (Kwakman et al., 2011).
Defensin-1 is an immunoactive peptide secreted by the
honeybee hypopharyngeal gland and ultimately transferred to
honey. The peptide has been detected in RS honey and
is responsible for antibacterial activity against Gram-positive
bacteria like Bacillus spp. Conversely, defensin-1 is not effective
against S. aureus if used alone, but is essential for honey
activity against this bacterial species, suggesting a possible
synergistic interaction with other honey components. Peptide-
dependent antibacterial activities have been found in other
honey types besides RS honey, possibly depending in some cases
on the presence of defensin-1. Other evidence for synergistic
interactions have been detected in the effect of RS honey on
E. coli and P. aeruginosa, requiring both H2O2 and MGO, and
on vancomycin-resistant Enterococcus faecium, requiring H2O2
in combination with either MGO or defensin-1 (Kwakman and
Zaat, 2012).
A specific study has been devoted to compare the antibacterial
mechanisms of action of Manuka and RS honey, showing
defensin-1 and H2O2 as major antibacterial factors of RS honey.
Conversely, in manuka honey these factors have not been
observed, while the antibacterial activity has been found to
depend on MGO and other unidentified factors (Kwakman et al.,
2011). However, another study has shown that the apparent lack
of defensin-1 in manuka would be due to an inactivation of the
peptide caused by MGO-induced modifications (Majtan et al.,
2012).
Other antibacterial factors isolated from honey are
glycoproteins with high-mannose N-glycans. These proteins
have displayed agglutinating and bactericidal activity on
different clinical isolates of multi drug resistant strains, such as
methicillin-resistant S. aureus MRSA, P. aeruginosa, Klebsiella
pneumoniae, vancomycin-resistant enterococci (VRE), and
extended-spectrum β-lactamase-producing (ESBL) Proteus
mirabilis, and E. coli. Q-TOF-MS analysis has shown extensive
homology of these peptides with the MRJP-1 precursor, which
harbors three antimicrobial jelleins typical of royal jelly.
These data indicate a role for high-mannose structures in the
antibacterial activity of honey glycoproteins (Brudzynski and
Sjaarda, 2015; Brudzynski et al., 2015).
Fractionation of an n-hexane extract of Citrus goldcrest
honey has led to the identification of a complex fraction with
inhibitory activity against a clarithromycin/metronidazole-
resistant Helicobacter pylori strain. This fraction contains
mostly acetic acid, 2,3-dihydro-3,5-dihydroxy-6-methyl-4H-
pyran-4-one, 2-propanone, butanal, 1,3-benzenediamine,
propanenitrile, 2-furanmethanol, propanoic acid, 1,3-butanediol,
1-(1-cyclopentenyl)-1-propanol, and 5-hydroxymethylfurfural
(Manyi-Loh et al., 2012). However, the specific role of each single
compound, or the presence of combinatory effects, has not been
ascertained.
Honey is also known for antimycotic effects, e.g., against
non-pathogenic Aureobasidium pullulans and Cladosporium
cladosporioides, and pathogenic Candida parapsilosis,
C. tropicalis, and Rhodotorula sp. (Kuncic et al., 2012; Moussa
et al., 2012). Evidence has been collected that flavonoids like
quercetin, kaempferol, chrysin, galangin, and apigenin may be
involved in honey activity against C. albicans (Candiracci et al.,
2011).
Antiparasitic Activity
Peptides from Ziziphus sp. honey with molecular masses ranging
from 2 to 200 kDa, separated by size-exclusion chromatography,
have shown antiprotozoal activity against the intestinal parasite
Giardia lamblia (Mohammed et al., 2015). In addition, three
different honeys from Plectranthus, Ziziphus, and acacia, have
been found to possess nematicidal activity against Caenorhabditis
elegans, which has been correlated to the presence of an
unidentified glycoconjugate of about 5 kDa (Sajid and Azim,
2012).
Anti-inflammatory Activity
An extract from Italian multifloral honey, containing the
flavonoids daidzein, apigenin, genistin, luteolin, kaempferol,
quercetin, and chrysin, as major components, has inhibited
the release of pro-inflammatory TNF-α and IL-1β from LPS-
stimulated N13 microglia cells (Candiracci et al., 2012). Given a
role of neuroinflammation in neurodegenerative diseases, these
data confirm possible use of the honey flavonoid fraction in
contrasting disorders like Alzheimer or Parkinson.
Immunomodulatory effects have been reported also for honey
proteins. MRJP-3 has been found to suppress IL-2, IL-4, and
IFN-γ production by antigen-stimulated T cells (Okamoto et al.,
2003). Glycopeptides and glycoproteins isolated from Ziziphus
honey, ranging from 2 to 450 kDa, have inhibited ROS release by
zymosan-activated human neutrophils and murine macrophages,
NO production and phagocytosis by LPS-activated murine
macrophages, and production of TNF-α by human monocytic
cells (Mesaik et al., 2015).
The honey protein apalbumin-1, aka MRJP-1, has been found
to block the mannose receptors of human phagocytic cells,
thereby inhibiting phagocytic activities. Such inhibitory effect
seems enhanced in MGO-containing honey, due to apalbumin
glycation (Molan and Rhodes, 2015).
Antidiabetic Activity
Honey has been found to reduce blood glucose in animal models
and in patients with impaired glucose tolerance or diabetes,
though clinical studies have not provided conclusive evidence.
Fructose is a potential antidiabetic agent, while the presence in
honey of a balanced mix of fructose and glucose could play
an additional role in this kind of effect, since the two sugars
are known to act synergistically in promoting liver glucose
metabolism (Erejuwa et al., 2012).
It has been shown that non-digestible, dietary
oligosaccharides, such as fructooligosaccharides,
galactooligosaccharides, and lactulose, have a preventive
role against obesity, insulin resistance, and diabetes mellitus,
by acting as prebiotics on the intestinal flora. Given that honey
contains oligosaccharides, it has been hypothesized that these
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compounds might contribute to honey prebiotic effects, and
therefore, that they could be linked to honey antidiabetic,
antihyperlipidemic and hepatoprotective virtues (Erejuwa et al.,
2014). However, experimental evidence in support of such
assumption is lacking.
Wound Healing
Honey has long been known for its healing capacity on wounds
and burns (Molan, 2006; Vandamme et al., 2013). Revamil R©
medical grade honey has been specifically developed for this
purpose, while another medical-grade, wound-dressing product
is SurgihoneyTM, consisting of engineered honey with enhanced
antimicrobial power (Al-Waili et al., 2011).
Antimicrobial activity is considered the most important factor
for honey wound healing. However, various studies indicate
that honey may also specifically act on skin cells involved
in the wound healing process (Majtan et al., 2010; Ranzato
et al., 2012). Various data have been collected on honey
immunomodulatory properties, which can at least partially
explain the ability of promoting wound healing. Even though
some authors have argued that honey immunostimulatory effects
may derive from bacterial lipopolysaccharide contamination,
possible immunomodulatory honey constituents have been
isolated. A 5.8 kDa constituent from manuka honey stimulates
TNF-α production by macrophages via toll-like receptors (Tonks
et al., 2007), while MRJP-1 induces TNF-α and metalloproteinase
9 (MMP-9) expression in keratinocytes (Majtan et al., 2010).
Kanuka honey from Kunzea ericoides, a close relative of the
manuka myrtle L. scoparium, contains type II arabinogalactans of
plant origin that have been shown to promote TNF-α production
by monocytic cell lines differentiated into macrophage by phorbol
myristate acetate (Gannabathula et al., 2012). An aqueous extract
rich in phenolics, obtained from fir honeydew honey, has been
found to inhibit TNF-α-induced MMP-9 production by human
keratinocytes, with a possible role for kaempferol and apigenin
(Majtan et al., 2013). Such a result is apparently in contrast with
another study reporting that different types of honey stimulate
MMP-9 expression in the same cells (Ranzato et al., 2012), but in
this latter case, whole honey has been used, possibly resulting in
a dominant stimulatory effect due to other components, like for
instance MRJPs.
Anticancer Activity
Inhibitory effects of honey on various kinds of cancer have
been studied both in vitro and in animal models (Erejuwa
et al., 2014). Polyphenols are known to possess chemopreventive
properties, and accordingly, it has been shown that honey
with higher phenolic charge is more potent in inhibiting
cancer cell proliferation (Jaganathan and Mandal, 2009). Various
polyphenols occurring in honey have been studied singularly
for their mechanisms of action on cancer models, including
caffeic acid and its phenyl esters, caffeoylquinic acid derivatives,
rosmarinic acid and derivatives, ellagic acid, as well as
the flavonoids chrysin, luteolin, acacetin, fisetin, myricetin,
wogonin, apigenin, hesperidin, galangin, quercetin, kaempferol,
pinobanksin, and pinocembrin (Jaganathan and Mandal, 2009;
Abubakar et al., 2012). However, direct evidence that these
compounds or their combinations are responsible for honey
anticancer activity is lacking.
A unique trihydroxyketone (E-4-(1,2,4-trihydroxy-2,6,6-
trimethylcyclohexyl)-but-3-en-2-one) from thyme honey,
endowed with antibacterial activity, has been shown to induce
apoptosis on PC-3 prostate cancer cells. Such an effect has
been put in relationship with the inhibition of p65 NF-KB
phosphorylation and IL-6 secretion, but these inhibitory
activities have been found at concentrations ranging between
1 and 100 µM, whereas apoptosis has been observed with the
100 µM dose only (Kassi et al., 2014).
Adverse Effects
Various occurrences of toxic compounds in honey have been
reported, such as polycyclic diterpene grayanotoxins in honey
from rhododendron plants like R. luteum and R. ponticum. This
kind of honey is known as “mad honey” since it may produce
severe neural intoxication up to fatal emergency, especially in the
eastern Black Sea region of Turkey. Grayanotoxins are known
to affect voltage-dependent Na+ channel gating. Possibly due to
this kind of action, and despite its toxicity, mad honey is used
as folk medicine for hypertension, sexual dysfunction, and other
ailments (Koca and Koca, 2007; Silici and Atayoglu, 2015).
Plants like Boraginaceae, Asteraceae, and Fabaceae produce
pyrrolizidine alkaloids that are not toxic per se but are converted
into harmful pyrrolic metabolites by liver after honey ingestion.
The presence of these alkaloids in typical honey botanical sources,
make these compounds a potential hazard for honey consumers
(Edgar et al., 2002).
Cases of intoxication from honey consumption in New
Zealand, characterized by delirium, seizures, and memory loss,
have been related to honey contamination by the neurotoxic
sesquiterpene lactones tutin and hyenanchin. These oxygenated
sesquiterpene picrotoxanes, targeting GABAergic and glycinergic
receptors, are ingested by honeybees collecting honeydew
produced by passionvine hoppers (Scolypopa australis) feeding
on sap of the poisonous shrub tutu (Coriaria spp.) (Fields et al.,
2014; Larsen et al., 2015). Other plant secondary metabolites,
which are found in honey and could induce deleterious effects
to humans, include hyoscyamine and hyoscine from Solanaceae,
saponins from Sapindaceae, strychnine and gelsemine from
Gelsemiaceae, oleandrin and oleandrigenin from Apocynaceae
(Islam et al., 2014).
Besides phytochemicals, honey can also be contaminated
by environmental pollutants, like heavy metals, pesticides, and
antibiotics. Moreover, prolonged honey storage or heating may
give rise to Maillard reaction products, such as the furans 5-
hydroxymethylfurfural from hexoses and furfural from pentoses
(Islam et al., 2014).
ROYAL JELLY
Royal jelly is a secretion of honeybee hypopharynx and
mandibular salivary glands. It is a white-yellowish, gelatinous,
acidic colloid, containing about 67% water (w/w), 16% sugar,
12.5% protein and amino acids, and 5% fat, with considerable
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variability among different sources. Minor royal jelly constituents
include enzymes, vitamins, phenolics, and minerals (Melliou and
Chinou, 2005).
Proteins are the most abundant dry matter fraction, consisting
for more than 80% of soluble glycoproteins named major royal
jelly proteins (MRJPs), of which nine members have been
described. These proteins are encoded by a family of genes
arranged in tandem array, sharing a common ancestor with the
Yellow protein family genes (Drapeau et al., 2006). MRJP-1 is the
most abundant one and consists of monomeric and oligomeric
forms. The oligomer, ranging between 350 and 420 kDa, can
be separated into 55 and 5 kDa units, identified as MRJP-1
monomers and the 5 kDa protein apisimin, which is believed
to act as subunit linker. MRJP-2, MRJP-3, MRJP-4 and MRJP-5
are glycoproteins ranging between 49 and 80 kDa (Tamura et al.,
2009).
The lipid fraction mostly consists of medium chain fatty
acids, terminally and/or internally hydroxylated, with terminal
mono- or dicarboxylic acid functions, either saturated or
monounsaturated at the 2-position. Major constituents are the
10-carbon atoms fatty acids trans-10-hydroxy-2-decenoic acid
(10-HDA), unique to royal jelly, and 10-hydroxydecanoic acid.
Sterols are also present in minor amounts (Li et al., 2013).
Royal jelly is fed until the 3rd day of life to larvae developing
into female workers and male drones, or until the end of the larval
period to selected individuals developing into queens. Moreover,
it is an exclusive food for adult queens throughout their life
(Fujita et al., 2013). The induction of larval development into
queen has been ascribed to major royal jelly proteins (MRJPs) and
a 57-kDa protein known as royalactin (Kamakura, 2011; Buttstedt
et al., 2013), although contrary opinions have been raised against
the alleged role of this latter (Buttstedt et al., 2016).
Royal jelly has been used since ancient times in traditional
medicine, especially in Asiatic apitherapy, but also in the ancient
Egypt. It is currently used in the pharmaceutical and cosmetic
fields, and marketed as an over-the-counter functional food.
Various studies have reported antimicrobial activities of royal
jelly against bacteria, fungi, and viruses, while in animal models,
hypotensive, antitumour, antihypercholesterolemic, and anti-
inflammatory activities have been observed (Ramadan and Al-
Ghamdi, 2012). Moreover, antidiabetic properties, positive effects
on benign prostatic hyperplasia, and wound healing of diabetic
foot ulcers have been verified in clinical trials (Siavash et al., 2015;
Khoshpey et al., 2016). Most studies concern crude royal jelly or
protein and lipid subfractions, but in several cases the activity of
singular compounds has been ascertained.
Antioxidant Activity
Small peptides consisting of 2–4 amino acid residues have been
reported to possess strong antioxidant activity. Most active ones
have tyrosine residues at the C-terminal, allowing hydroxyl
radical and H2O2 scavenging activities (Guo et al., 2009).
Antimicrobial Activity
The above-mentioned jelleins are four 8–9 amino acid peptides,
of which jellein-I, -II, and -IV are cleavage products of
MRJP-1. Antimicrobial assays conducted against the gram-
positive S. aureus, S. saprophyticus, and B. subtilis, the gram
negative E. coli, E. cloacae, K. pneumoniae, and P. aeruginosa, and
the yeast C. albicans have shown that jellein-I and -II have broad-
spectrum activity, jellein-III is less active, and jellein-IV has no
antimicrobial effect (Fontana et al., 2004).
Royalisin is a 51 amino acid peptide, homologous to the
haemolymph defensin-1, with antibacterial activity against
various gram-positive strains, including Staphylococcus,
Streptococcus, B. subtilis, Micrococcus luteus, Sarcina lutea,
Clostridium, Corynebacterium, Lactobacillus helveticus,
Paenibacillus larvae, and Leuconostoc, while no inhibition
has been observed against the gram negative E. coli and Serratia
marcescens. Antifungal activity against Botrytis cinerea has also
been reported for royalisin (Fujiwara et al., 1990; Bachanova
et al., 2002). In addition, a variant of MRJP-2, known as
apalbumin 2a, has been found to inhibit the growth of P. larvae,
B. subtilis, and E. coli (Bilikova et al., 2009).
Royal jelly carboxylic acids are known to collectively exert
antimicrobial properties against gram-positive, gram-negative
bacteria, and fungi. 10-HDA has been identified as a particularly
strong antibacterial, especially against B. subtilis, S. aureus,
and E. coli (Alreshoodi and Sultanbawa, 2015). Moreover, the
compound has been shown to interfere with the adherence to
cell surfaces of the oral pathogen S. mutans, by interfering with
the expression of the glucosyltransferases gtfB and gtfC (Yousefi
et al., 2012). Strong antifungal activity against C. albicans,
C. tropicalis, and C. glabrata has been reported for sebacic acid
(Melliou and Chinou, 2005).
Anti-inflammatory Activity
In a study on royal jelly potential for digestive trait diseases, 10-
HDA has been found to protect rats from experimentally induced
gastric ulcer (Fang et al., 1994). A mechanism putatively linked
to 10-HDA anti-inflammatory effect is the inhibition of LPS-
induced NF-κB activation observed in the murine macrophage
cell line RAW264 (Sugiyama et al., 2012).
10-HDA and 4-hydroperoxy-2-decenoic acid ethyl ester have
been shown to inhibit histone deacetylase activity, thereby
enhancing the expression of extracellular SOD release by
leukemia THP-1 cells, and suggesting therapeutic potential
against atherosclerosis (Makino et al., 2016). Histone deacetylase
inhibition by 10-HDA is thought to reactivate the expression
of epigenetically silenced genes in mammalian cells, leading to
the hypothesis that a similar effect could be at the basis of
caste switching in bees (Spannhoff et al., 2011). Modifications of
histone acetylation have also emerged from a study showing 10-
HDA inhibition of fibroblast-like synoviocytes from rheumatoid
arthritis patients, suggesting potential therapeutic effects against
chronic inflammation degenerative disease (Wang et al., 2015).
Immunomodulatory Activity
Experimental evidence has been collected arguing for royal jelly
immunomodulatory properties. A 57 kDa and 350-kDa royal jelly
proteins, purportedly monomeric and oligomeric MRJP-1, have
been reported to stimulate the proliferation of in vitro cultured
hepatocytes and monocytes, respectively (Kamakura et al., 2001;
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Kimura et al., 2003). As a confirmation, an in vitro study has
shown that the MRJP-1 oligomer, but not MRJP-2 or MRJP-3,
induces the proliferation of the human lymphoid cell line Jurkat
(Moriyama et al., 2015). MRJP-1 and MRJP-2 have been found
to exert immunostimulatory and proinflammatory activities by
stimulating cytokine release, such as TNF-α, from macrophages
(Simuth et al., 2004; Majtan et al., 2006). In contrast, MRJP-3
has been reported to suppress interleukin production by T cells
both in vitro and in vivo, reconducible to antiallergic properties
(Okamoto et al., 2003).
Various immunomodulatory activities have been reported for
10-HDA, including reduced T cell proliferation, inhibition of
interleukin-12 production by spleen dendritic cells, and block of
LPS- and IFN-β-induced NO production in macrophages (Gasic
et al., 2007; Sugiyama et al., 2013). In another study, a biphasic
behavior of 10-HDA on human monocyte-derived dendritic cells
has been found, resulting in Th1 response stimulation and Th2
downregulation at 50µM, and repression of both Th1 and Th2 at
500 µM (Mihajlovic et al., 2013).
Another hydroxyl fatty acid, 3,10-dihydroxydecanoic acid, has
been reported to stimulate the maturation of human monocyte-
derived dendritic cells and their Th1 polarizing capability,
suggesting a reinforcement of antitumour and antiviral immunity
(Dzopalic et al., 2011). The immunomodulatory properties of
royal jelly lipids suggest their possible use in interventions on
autoimmune diseases.
Metabolic Syndrome Preventing Activity
The royal jelly proteins MRJP-1, MRJP-2, and MRJP-3 have
been shown to possess bile acid-binding properties. The most
active one is MRJP-1, which in rats has increased fecal bile acids
and cholesterol excretion, and has powered hepatic cholesterol
catabolism (Kashima et al., 2014). In a study aimed at disclosing
royal jelly antihypertensive mechanisms, MRJP-1 has been
transfected into vascular smooth muscle cells, leading to a
reduction of contraction, migration and proliferation (Fan et al.,
2016).
A study conducted both in vitro on L6 myotubes, and
in vivo on mice, has demonstrated that 10-HDA enhances
insulin-independent muscle glucose uptake via AMP-activated
protein kinase activation and GLUT4 translocation to the plasma
membrane (Takikawa et al., 2013). Moreover, this fatty acid has
been found to improve hyperlipidemic condition in a rat model
(Xu et al., 2002).
Anti-aging Activity
Royal jelly is known to extend the lifespan of honeybees.
This property is at least in part due to royalactin, which has
been found to induce such effect in other insect species, like
Drosophila melanogaster, as well as in non-insect species, like the
nematode C. elegans (Detienne et al., 2014). Moreover, also10-
HDA has been found to increase longevity and confer thermal
and oxidative stress tolerance to C. elegans, possibly through
dietary restriction and TOR kinase signaling (Honda et al., 2015).
Royal jelly has estrogen-like effects, which in different studies
have been ascribed to the ability of different lipids to act
as weak activators of estrogen receptors. These constituents
include 10-HDA, trans-2-decenoic, 10-hydroxydecanoic, 3,10-
dihydroxydecanoic, and sebacic acids, and in addition the steroid
24-methylenecholesterol (Suzuki et al., 2008; Moutsatsou et al.,
2010). These results have been proposed as a pharmacological
basis for an anti-menopause use of royal jelly.
10-HDA has been shown to increase collagen synthesis
and production of the collagen promoting factor, transforming
growth factor β1, in human skin fibroblasts. Such an effect is
thought to mediate royal jelly skin protection against UVB-
induced photoaging (Koya-Miyata et al., 2004; Park et al.,
2011). In addition to promoting collagen synthesis, 10-HDA has
been found to inhibit the release of the MMP-1 and MMP-3
from rheumatoid arthritis synovial fibroblasts, possibly through
downregulation of the pathway involving JNK/p38 MAP kinases
and AP-1 transcription factor (Yang et al., 2010), and of the MMP
regulator connective tissue growth factor (Wang et al., 2012). 10-
HDA has also prevented UVA-induced JNK/p38 activation and
MMP-1 and MMP-3 upregulation in fibroblasts (Zheng et al.,
2013).
Such a complex of effects suggest skin dermal protection
and antirheumatoid activity, but in most cases concentrations
ranging around the millimolar level have been used, apparently
with low clinical feasibility. However, a registered, synthetic 10-
HDA counterpart, known as Hydroxydecine R©, has been shown
to activate keratinocyte differentiation in vitro, to restore skin
barrier function in skin equivalents, and to improve UV-induced
xerosis in human volunteers (Duplan et al., 2011).
Neuromodulatory Activity
10-HDA and 10-hydroxydecanoic acid have been shown to
act as potent agonists of the human TRPA1 and TRPV1
receptors (Terada et al., 2011). 10-HDA has stimulated neuron
differentiation from rat embryo neural stem cells, possibly acting
like the ω-3 docosahexaenoic acid, an essential diet component
that is known to promote neurogenesis in the central nervous
system. Docosahexaenoic acid is reputed essential for brain
development and function and has shown positive effects in a
rat Parkinson’s model, suggesting similar potentials for 10-HDA,
which in addition could cross more easily the blood-brain barrier
due to its smaller molecule (Hattori et al., 2007). Neurogenerative
potentials of royal jelly fatty acids are also suggested by a study
on synthetic, medium-chain fatty acids, in which 2-decenoic acid
ethyl ester, a derivative of the royal jelly 2-decenoic acid, has
promoted functional recovery in a rat model of spinal cord injury
(Hirakawa et al., 2010).
Adverse Effects
Similarly to honey, environmental contaminants can also be
present in royal jelly. Most common ones are pesticides belonging
to organochlorines, organophosphorus and carbamates, which
are generally below Minimal Risk Level. However, in some cases
the highly toxic, zero-tolerance chloramphenicol has been found
(Bogdanov, 2006).
Royal jelly consumption can occasionally lead to contact
dermatitis, asthma and anaphylaxis, while MRJP-1 and MRJP-2
have been identified as major allergens (Rosmilah et al., 2008).
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PROPOLIS
Propolis is a resinous substance that foraging bees produce
by collecting resin from buds and other plant tissues and
then mixing it with wax and pollen to have a malleable,
compact substance that they use as hive repairing material
and sanitizer (Sun et al., 2015). The chemical composition
of propolis is dramatically dependent on its geographical and
floral origins. Raw propolis generally contains more than 300
different compounds, mostly consisting of triterpenes (50% w/w),
waxes (25–30%), volatile mono- and sesquiterpenes (8–12%),
giving propolis its typical resinous odor, and phenolics (5–10%)
(Huang et al., 2014). European and Asian propolis contain
simple phenolic acids (Bankova et al., 2002), while lignans are
main compounds in tropical propolis (Petrova et al., 2010).
Caffeic acid phenethyl ester (CAPE) is a major active found in
European, Asian and American propolis (Omene et al., 2013).
Brazilian green propolis is characterized by the presence of
the 3,5-diprenyl-4-hydroxycinnamic acid artepillin C, together
with other prenylated cinnamic acids and caffeic acid derivatives
(Marcucci et al., 2001). Other propolis common constituents
include organic acids, ketones, aldehydes, hydrocarbons, and
minerals (Wagh, 2013).
Antioxidant Activity
Propolis is the bee product containing the highest amount of
phenolics and thus it has been deeply studied for antioxidant and
radical scavenging activities (Viuda-Martos et al., 2008). Several
of these compounds possess strong antioxidant and antiradicalic
activities, including pinocembrin, chrysin, and pinobanksin (Sun
et al., 2015). In DPPH and ORAC tests, pinobanksin-3-acetate
has been indicated as the strongest antioxidant constituent
(Boisard et al., 2014).
Antimicrobial Activity
The antimicrobial activity of propolis has been demonstrated
in clinical, in vivo, and in vitro studies. Propolis possesses
antibacterial properties against Gram positive and negative
strains, also validated in clinical trials (Noronha et al., 2014).
Sensitive strains include MRSA, VRE, Streptococcus species, and
H. pylori (Kosalec et al., 2005; Coelho et al., 2007).
Propolis antibacterial effects are possibly related to the
presence of such flavonoids as galangin, pinocembrin,
rutin, quercetin, and naringenin, as well as of CAPE, since
these compounds are known to increase bacterial membrane
permeability (Stepanovic et al., 2003). Inhibition of bacterial RNA
polymerase has been also considered for galangin, pinocembrin,
and CAPE (Speciale et al., 2006). The antimicrobial activity
of Brazilian red propolis is thought to depend on its peculiar
content in isoflavones (Freires et al., 2016).
Antibacterial effectiveness has been demonstrated for
different propolis volatile fractions, including β-eudesmol
and δ-cadinene in Bulgarian propolis, α-pinene and trans-
β-terpineol in Greek propolis, β-eudesmol and benzyl benzoate
in Hungarian propolis, nerolidol, spatulenol and ledol in Canary
Island propolis, and farnesol, dihydroeudesmol and guaiol
in Polish propolis (Bankova et al., 2014). The antibacterial
activity of Brazilian propolis has been demonstrated for its
volatile fractions containing nerolidol, spatulenol, p-cimen-8-ol,
ethylphenol, β-caryophyllene, acetophenone, α-pinene, β-pinene
and limonene (Bankova et al., 2014).
Propolis has been shown to act as an antifungal agent against
pathogenic yeasts like C. albicans, C. parapsilosis, C. tropicalis,
and C. glabrata (Al-Waili et al., 2012; Mutlu Sariguzel et al.,
2016). Antifungal activity has been shown for volatile compounds
from Brazilian propolis, viz. α-pinene, β-pinene and δ-cadinene,
and from Turkish propolis, viz. phenyl-, ethyl-, and benzyl
alcohol, and decanal (Ioshida et al., 2010). The ethanolic
extracts of Iranian propolis have shown strong anti-C. albicans
activity imputable to inhibition of germ tube development by
phenolic, aromatic, and aliphatic acids (Haghdoost et al., 2016).
Another ethanolic extract containing CAPE and other caffeic acid
derivatives has been effective against C. albicans, C. dubliniensis,
C. glabrata, C. krusei, C. tropicalis, and C. parapsilosis, with
an MFC of 125-500 mg/L, while red Brazilian propolis rich
in triterpenes and isoflavones, such as medicarpin, vestitol and
formononetin, has shown the same MFC range (Freires et al.,
2016).
Antiviral Activity
Propolis is well known for its antiviral activity, which in some
cases can exceed that of standard drugs. For instance, an
ointment containing Canadian propolis has produced better
results than acyclovir or placebo in the clinical treatment
of genital herpes simplex (Vynograd et al., 2000). Antiviral
properties seem to depend mainly on the presence of CAPE
and related compounds. CAPE has been found to inhibit
the activity of HIV-1 by acting on viral integrase (Costi
et al., 2004), and to suppress hepatitis C virus replication
in vitro (Zhang et al., 2003). Turkish Hatay propolis containing
caffeic acid derivatives has been effective on herpes simplex
virus 1 and 2 (Yildirim et al., 2016). 3,4-Dicaffeoylquinic
acid, a major constituent of Brazilian green propolis, has
repressed influenza A virus in mice by upregulating the TNF-
related, apoptosis-inducing ligand (TRAIL) (Takemura et al.,
2012).
Immunomodulatory Activity
Propolis is generally known to modulate immune responses (Orsi
et al., 2000), and this kind of effects could explain to some extent
its antimicrobial and antiviral activities.
Brazilian green propolis standardized in 18.9% w/w
polyphenols, 9.85% flavonoids and 2.3 artepillin C, administered
to old mice, has enhanced phagocytosis, production of antibodies
against sheep erythrocytes, and ear swelling (Gao et al., 2014).
Brazilian green propolis and artepillin C have both inhibited
in vitro alloreactive CD4+ T cell responses, together with
the expression of IL-2, IL-17, and IFN-γ. In healthy subjects
and asthmatic patients, CAPE has inhibited IL-5 and IFN-γ
production, and the proliferation of CD4+ T cells stimulated
by soluble anti-CD3 and anti-CD28 monoclonal antibodies,
by targeting NF-κB and AKT/PKB pathways (Wang et al.,
2010).
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Anti-inflammatory Activity
Many studies have reported anti-inflammatory properties of
propolis, possibly linked to the presence of phenolic acids.
CAPE is considered a particularly strong anti-inflammatory
constituent, able to specifically target NF-κB signaling (Armutcu
et al., 2015). This compound has been also found to modulate
ERK MAPK signaling in T cells and mastocytes (Cho et al.,
2014), and to regulate PI3K/Akt pathway in different human
cell lines (Li et al., 2017). Possible downstream effects
of these anti-inflammatory mechanisms may include the
downregulation of key inflammatory enzymes, like xanthine
oxidase, cyclooxygenase, matrix metalloproteinases, and
inducible nitric oxide synthase (Armutcu et al., 2015; Li et al.,
2017).
Anti-inflammatory virtues of propolis are popularly exploited
in mouthwash products. Antigingivitis activity has been
ascribed to phenolics, especially CAPE (Li et al., 2017).
Moreover, in randomized, double-blind, placebo-controlled
trials, rinse products containing Brazilian green propolis rich
in artepillin C have alleviated gingivitis to the same extent of a
NaF/cetylpyridinium chloride rinse or a chlorhexidine solution
(Bretz et al., 2014).
Propolis is also lenitive to the skin by topical application.
Australian and Romanian propolis have induced photo-
protective effects on animal models, possibly due to the anti-UV
properties of polyphenols (Cole et al., 2010; Bolfa et al., 2013).
Wound Healing and Skin Protection
Animal models and clinical trials have shown the healing
effect of propolis on diabetic foot ulcers and other problematic
tissue injuries (Henshaw et al., 2014; Abu-Seida, 2015). Propolis
wound healing activities are favored by the immunomodulatory,
antioxidant and antiseptic effects of its rich phytocomplex
(Martinotti and Ranzato, 2015). However, other mechanisms
seem to play a role, since molecular studies have revealed
that propolis modulates fibronectin expression and collagen
I and III deposition in burns (Olczyk et al., 2013). An
Indian propolis containing flavonoids, phenolic acids and
terpenes, topically applied to rats with excision wounds,
has upregulated hydroxyproline, hexosamine, uronic acid,
nucleic acids and protein levels in wounded tissue, similar
to the effect of nitrofurazone (Iyyam Pillai et al., 2010). In
addition, in a study on Wistar rats, Brazilian green propolis
rich in artepillin C has revealed superior wound healing
activity with respect to Brazilian red propolis (Batista et al.,
2012).
Anticancer Activity
A very large number of in vitro and pre-clinical studies on
propolis anticancer effects are available, while only few clinical
studies have been conducted and their results are controversial.
Propolis from Aydin, Turkey, rich in CAPE and flavonoids, has
shown a concentration-dependent apoptotic effect on CCRF-
SB lymphoblastic leukemic cells involving the modulation of
different miRNA expressions (Yilmaz et al., 2016). New Zealand
propolis and its constituents chrysin, galangin, CAPE, benzyl
ferulate, benzyl isoferulate, pinostrobin, 5-phenylpenta-2,4-
dienoic acid, and tectochrysin, have exhibited antiproliferative
effects on DLD-1 colon cancer, HCT-116 colon carcinoma,
KYSE-30 esophageal squamous cancer, and NCI-N87 gastric
carcinoma cells (Catchpole et al., 2015). Polish propolis rich in
phenolic acids and flavonoids has been shown to possess dose-
dependent antiproliferative and proapoptotic activities on HCT
116 colon cancer and Me45 malignant melanoma cells (Kubina
et al., 2015).
Various mechanisms of action have been disclosed for CAPE,
including suppression of tyrosine kinase activity and induction
of cell cycle arrest in G1 or G2/M phase (Patel, 2016), block of
migration and invasiveness through Wnt inhibition and ROR2
upregulation (Tseng et al., 2016), voltage-gated sodium channel
block leading to reduction of breast cancer cell motility and
invasiveness (Fraser et al., 2016), and selective inhibition of
cancerous cell viability (Kuo et al., 2015). Moreover, CAPE seems
synergistic with tamoxifen on MCF-7 breast cancer cells (Motawi
et al., 2016), and has induced radiosensitivity on MDA-MB-
231 (estrogen receptor negative) and T47D (estrogen receptor
positive) breast cancer cell lines (Khoram et al., 2016).
The flavone chrysin has exerted an antiproliferative effect
on human Hep-3B, TCC, A549, HeLa, and colorectal cancer
cells (Patel, 2016), while possible mechanisms of action
include TRAIL-induced caspase activation and STAT3 inhibition
(Lirdprapamongkol et al., 2013), as well as p38 and Bax
activation (Pichichero et al., 2011). Artepillin C has induced
an antiproliferative effect on prostate cancer cells by reducing
TRAIL resistance and inhibiting NF-κB, while a proapoptotic
effect of galangin has been related to the induction of MAPK
phosphorylation (Zhang et al., 2013).
A study on M12.C3.F6 B-cell lymphoma cancer cell line
has shown that pinobanksin, pinobanksin-3-O-propanoate,
pinobanksin-3-O-butyrate and pinobanksin-3-O-pentanoate
exert an antiproliferative effect by inducing loss of mitochondrial
membrane potential and activating caspases 3, 8 and 9 (Alday
et al., 2015). Similarly, the phenolic lipids cardanol and cardol
from Thai propolis have shown antiproliferative effects on
several human cancer cells (Teerasripreecha et al., 2012), while
cardanol has also induced apoptosis in BT-474 breast cancer cells,
upregulated p21, stimulated ERK, p38 and JNK phosphorylation,
and downregulated cyclin D (Buahorm et al., 2015). Finally,
the polycyclic, polyisoprenylated benzophenone nemorosone
from Cuban propolis has shown anticancer effects on estrogen
receptor-positive MCF-7 cells by blocking cell cycle in G0/G1,
and reducing MAPK and Akt phosphorylation (Popolo et al.,
2011).
Adverse Effects
Clinical and in vivo studies on animal models have reported
that propolis is well tolerated and non-toxic. The No Observed
Adverse Effect Level (NOAEL) on mice and rats is over
1,470 mg/Kg/day at 60 days, and over 2,470 mg/Kg/day at
90 days (Burdock, 1998). In humans, toxic effects occur at dosages
as high as 15 g/die (Castaldo and Capasso, 2002). However,
despite its favorable safety profile, propolis is a common cause
of allergic reactions. It has been reported that 1.2–6.6% of
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patients with dermatitis are sensitive to propolis (Walgrave et al.,
2005), while major sensitizers are 3-methyl-2-butenyl caffeate,
phenylethyl caffeate, benzyl salicylate, benzyl cinnamate, and 1,1-
dimethylallylcaffeic acid (Burdock, 1998; Walgrave et al., 2005).
BEE VENOM
Bee venom, also known as apitoxin, is a complex fluid
secreted by the bee venom gland located in the abdominal
cavity and injected into victims by a stinger, causing local
inflammation, anticoagulant effect, and immune response. Bee
venom constituents include amphipathic polycationic peptides,
of which major ones are melittin and apamin, enzymes such
as phospholipase A2, and low-molecular weight compounds
including active bioamines such as histamine and catecholamines
(Lee et al., 2016).
The venom has been traditionally, used in acupuncture
and apitherapy, consisting in its injection to the patient as
analgesic, against chronic pain and inflammation, and for other
purposes such as immunotherapy and Parkinson’s treatment.
A number of anticancer effects have been reported, together with
antimutagenic, antinociceptive, and radioprotective properties.
Approved pharmaceutical use has been introduced, while
attempts at validating clinical treatment for chronic pain have
been made (Moreno and Giralt, 2015; Sobral et al., 2016).
However, different bee venom constituents are allergenic and
in hypersensitive people bee sting can arrive to produce fatal
outcome (Gelder et al., 1996).
Melittin
Melittin is a peptide of 26 amino acid residues, with a prevalently
hydrophobic N-terminus and a hydrophilic C-terminus. It has
distinct biological activities and has attracted much interest from
pharmacological and biotechnological points of view.
The toxicity mechanism consists in the disruption of
phospholipid bilayers, leading to cell lysis and the release of tissue
injurious compounds such as lysosomal enzymes, serotonin,
and histamine, triggering inflammation and pain (Raghuraman
and Chattopadhyay, 2007). Together with hyaluronidase and
phospholipase A2, melittin is responsible for venom allergenic
properties. It seems also a major cause of pain induction by the
bee venom, through activation of TRPV receptors and release
of algogens from injured cells (Chen et al., 2016). In contrast to
its toxicity, melittin is known as a traditional anti-inflammatory
remedy for various diseases, such as dermatitis, neuritis, liver
inflammation, atherosclerosis, and arthritis, but the mechanism
of action at the cellular level has not been clarified (Lee and
Bae, 2016). A possible coherent mechanism of antiatherosclerotic
effects of melittin consists in the inhibition of vascular smooth
muscle proliferation through the hindrance of platelet-derived
growth factor beta-receptor signaling (Son et al., 2007).
The ability of interacting with biological membranes confers
strong antimicrobial properties to melittin, which have attracted
interest for fighting human pathogens, such as methicillin-
resistant S. aureus (Choi et al., 2015), as well as plant pathogens
(Stockwell and Duffy, 2012). Anticancer activities of melittin have
been reported by different sources, while attempts at clarifying
molecular mechanisms have been made by in vitro studies (Gajski
and Garaj-Vrhovac, 2013). It has been shown for instance that
melittin induces apoptosis in human ovarian cancer cells, SKOV3
and PA-1, by increasing the expression levels of the DR3, DR4,
and DR6 death receptors (Jo et al., 2012).
Despite many indications of possible therapeutic applications
of melittin, in vivo injection is known to entails side effects
like hemolysis and liver injury, which have stimulated studies
for the development of non-toxic hybrid derivatives. Engineered
melittin peptides have also been developed for different
biotechnological applications, e.g., to enhance antimicrobial
properties or promote siRNA release from endosomes into target
cells. (Moreno and Giralt, 2015).
Apamin
Apamin is a peptide of 18 amino acids, tightly cross-linked by the
presence of two disulphide bonds (Habermann, 1984). It exerts
a highly specific toxicity mechanism, consisting in a block of
small conductance Ca2+-dependent K+ channels (SK channels)
expressed in the central nervous system and in other districts, like
the cardiovascular system and smooth muscle (Adelman et al.,
2012).
Due to its ability of selectively targeting SK channels, apamin
has been used as a tool for the physiological characterizations
of this kind of K+ conductance (Castle et al., 1989). On a
pharmacological ground, such a property has been adopted
as an explanatory paradigm for accumulating evidence that
apamin facilitates learning and memory. Apamin can cross
the blood-brain barrier, and its administration to animals
improves cognitive deficits, suggesting that SK channels would
be appropriate apamin targets in the treatment of these neural
disorders (Deschaux and Bizot, 2005; Brennan et al., 2008). In
addition, the possibility of using apamin or less toxic analogs
as blood-brain barrier, drug-delivery shuttles has been explored
(Oller-Salvia et al., 2013).
SK channels are known to be involved in the pathogenesis
of Parkinson’s disease. Consistent with this premise, another
important perspective for neuro-therapeutic uses of apamin
derives from its ability of protecting dopaminergic neurons from
degeneration in experimental models of Parkinson’s (Alvarez-
Fischer et al., 2013; Thomas and Justin, 2013). Among other
possible uses, experimental work has shown antiatherosclerotic
effects of apamin administered to mice (Kim et al., 2012), while as
a K+ channel blocker, apamin can be useful for long-term whole
blood storage (Delgado and Pitt, 2008).
Phospholipase A2
Phospholipase A2 (PLA2) hydrolyzes complex lipids to
produce a fatty acid and various reaction products, including
lysophosphatidic acid, lysophosphatidylcholine, and sphingosine
phosphate. These latters exert cytotoxic and immunostimulatory
effects on various cell types, eventually triggering immune
responses and inflammation.
Phospholipase A2 is the major allergen of bee venom,
containing three peptide and one glycopeptide T cell epitopes
recognized by allergic and non-allergic subjects (Dhillon
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et al., 1992; Okano et al., 1999). However, PLA2 has also
properties translatable into therapeutic treatments. It has exerted
neuroprotective effects in a mouse model of Parkinson’s disease
by activating regulatory T lymphocytes (Treg) that are known
to mediate peripheral immune tolerance (Chung et al., 2015).
Systemic PLA2 administration to a mouse model of neuropathic
pain has alleviated cold and mechanical allodynia through
the activation of α2-adrenegic receptors (Li et al., 2015).
It has also been shown that PLA2 acts cooperatively with
phosphatidylinositol-(3,4)-bisphosphate in inducing in vitro lysis
of different tumor cell lines (Putz et al., 2006).
Minor Peptides and Enzymes
The second major allergen of honeybee venom is hyaluronidase
(Padavattan et al., 2007), while other allergenic peptides include
icarapin isolated from A. cerana (Wong et al., 2012), and two
serine proteases named Api SI and Api SII belonging to the
prophenoloxidase activating factor II family (Georgieva et al.,
2011). Another serine protease of this family, named Bi-VSP, has
a dual behavior, since in arthropods it triggers the phenoloxidase
cascade inducing a lethal immune response, while in mammals
it acts as a toxic thrombin-like and plasmin-like fibrinolytic
protease (Choo et al., 2010).
Secapin is a serine protease inhibitor-like peptide exerting
anti-fibrinolytic and anti-elastolytic activities, and also displaying
antimicrobial properties by binding to the surfaces of fungi and
bacteria (Lee et al., 2016). Two peptides isolated from A. cerana
venom, viz. an inhibitor cysteine knot (ICK) peptide and a
Kazal-type serine protease inhibitor, have been shown to act as
antibacterial, antifungal and insecticidal venom toxins (Kim et al.,
2013; Park et al., 2014).
Tertiapin is a 21 amino acid neurotoxin blocking inward-
rectifier K+ channels expressed in epithelial cells, heart,
and central nervous system. In the heart, tertiapin contrasts
G-protein-gated, acetylcholine-activated K+ current that mediate
parasympathetic heart rate decrease. This toxin could be allegedly
useful as a drug for treating disorders in atrio-ventricular
transmission, but at present it is used solely as a tool for K+
channel modulation (Drici et al., 2000).
Mast cell degranulating (MCD) peptide is a 22-amino acid
peptide with two disulfide bridges, structurally similar to apamin
but with different mechanisms of action. At low concentrations,
MCD induces mast cell degranulation through histamine release,
while at higher concentrations it can produce anti-inflammatory
effects (Buku, 1999). Moreover, MCD also acts as a neurotoxin
by blocking fast-inactivating (A-type) and slow-inactivating
(delayed rectifier) K+ channels, thereby increasing neuronal
excitability. Long term potentiation in the hippocampus CA1
region has been experimentally observed, while direct brain
injection leads to convulsions and neurodegeneration (Mourre
et al., 1997).
BEE POLLEN
Foraging bees bring pollen back to the hive where it is packed
into pellets and stored. During this process, the pollen mixed
with nectar and bee salivary secretions becomes the “bee bread,”
representing a main food reserve for the hive colony (Almeida-
Muradian et al., 2005).
Main chemical compounds of bee pollen include
carbohydrates, proteins and amino acids, lipids and fatty
acids, phenolics, enzymes and coenzymes, vitamins and minerals
(Komosinska-Vassev et al., 2015). However, the chemical
composition of bee pollen is highly variable, depending on plant
source, geographical region, and climatic conditions, thus deeply
affecting biological properties and therapeutic virtues (Denisow
and Denisow-Pietrzyk, 2016).
Bee pollen is an energy food used by humans as a diet
supplement and for the conditioning of athletes. The high content
of protein, fat, and minerals (particularly Ca, Mg, Fe, and P) gives
bee pollen a nutritional value similar to, or higher than, that of
dried legumes. Among vitamins, the levels of pantothenic and
nicotinic acids are close to those of beef, ascorbic acid is similar to
that of vegetables, such as lettuce and tomatoes, and riboflavin is
comparable to that of skimmed milk power (Linskens and Jorde,
1997).
Bee pollen is used in complementary and alternative
medicine to cure prostatitis, stomach ulcers, infectious
diseases, and for the prevention and treatment of high-
altitude-sickness syndrome (Linskens and Jorde, 1997).
A wide range of therapeutic properties have been suggested,
including antimicrobic, antioxidant, hepatoprotective,
chemopreventive and anticarcinogenic, antiatherosclerotic,
anti-inflammatory, antiallergenic, and immunomodulatory
activities (Komosinska-Vassev et al., 2015; Denisow and
Denisow-Pietrzyk, 2016).
Antioxidant Activity
The antioxidant activity of bee pollen seems to be mainly
due to phenolic acids, like vanillic, protocatechuic, gallic, and
p-coumaric acids, and to flavonoids like hesperidin, rutin,
kaempferol, apigenin, luteolin, quercetin, and isorhamnetin.
These compounds are thought to inactivate electrophiles and
scavenge free radicals and reactive oxygen species (Bonvehí et al.,
2001; Pascoal et al., 2014).
Antimicrobial Activity
Antimicrobial effects of bee pollen are well known, possibly
mediated by glucose oxidase activity, deriving from honeybee
secretion, while plant phenolics and flavonoids could also
be involved (Denisow and Denisow-Pietrzyk, 2016; Fatrcova-
Sramkova et al., 2016). Evidence about the activity of phenolic
compounds from bee pollen extracts against Gram-positive
and Gram-negative pathogenic bacteria, microscopic fungi and
yeasts, has been reported (Baltrušaityte˙ et al., 2007; Kacániová
et al., 2012).
Anti-inflammatory Activity
Bee pollen exerts anti-inflammatory effects that have been
compared to those of common non-steroidal anti-inflammatory
drugs, possibly depending on the activity of flavonoids,
phenolic acids, phytosterols, and flavoring substances like
anethole, an inhibitor of the NF-KB pathway (Middleton,
Frontiers in Pharmacology | www.frontiersin.org 10 June 2017 | Volume 8 | Article 412
fphar-08-00412 June 24, 2017 Time: 15:5 # 11
Cornara et al. Properties of Compounds from Honeybee Products
1998; Choi, 2007). Specific effects include the capability
of removing swellings caused by cardiovascular and renal
pathologies (Yakusheva, 2010), of protecting the liver from
carbon tetrachloride-induced damages (Yildiz et al., 2013), and
of alleviating prostate inflammation and hyperplasia (Yakusheva,
2010). Positive effects on prostatic conditions have been
also ascribed to antiandrogen actions (Rzepecka-Stojko et al.,
2012).
Anticancer Activity
Different studies have shown potential anticancer activity of bee
pollen, probably associated with antioxidant and antimutagenic
potentials (Denisow and Denisow-Pietrzyk, 2016). The steroid
fraction of a chloroform extract from Brassica campestris bee
pollen has shown strong cytotoxicity on human prostate cancer
PC-3 cells, associated to stimulation of TNF-α secretion and
apoptosis induction (Wu and Lou, 2007).
Antiatherosclerotic and Antidiabetic
Activities
Bee pollen has shown antiatherosclerotic and cardioprotective
effects and has been successfully applied to patients who did not
respond to classical drugs (Polanski et al., 1998). Hypolipidemic
activity, confirmed by pharmacological studies conducted on rats
and rabbits, has been ascribed to the presence of unsaturated fatty
acids, especially the ω-3, α-linolenic acid, and to phospholipids
and phytosterols (Komosinska-Vassev et al., 2015). α-Linolenic
acid is a precursor of prostaglandin-3a that is considered a major
inhibitor of platelet aggregation (Denisow and Denisow-Pietrzyk,
2016).
Ghoshal and Saoji (2013) have found the presence of
antidiabetic compounds in pollen grains, such as steroids and
alkaloids in the pollen of C. roseus, saponins, flavonoids,
sugars, and tannins in M. charantia, sugars, flavonoids and
sterols in B. monosperma, and alkaloids and tannins in
S. cuminii, suggesting therapeutic possibilities for bee pollen as
a hypoglycemic agent.
Immunomodulatory Activity
Evidence of antiallergic activity of bee pollen has been reported,
including prevention of IgE binding to their high-affinity
receptor FcεRI, inhibition of histamine release from mast cells,
and basophil degranulation (Ishikawa et al., 2008; Moita et al.,
2014). Flavonoids, steroids, and volatile oil compounds seem to
be involved in immunosuppressive activities.
Nutritional Properties
Bee pollen has been used as a diet supplement in recovery
periods, in cases of malnutrition, asthenia and apathy, and
to increase physical and mental ability or strengthen the
immune system. Experiments on animals have shown that the
administration of bee pollen prolongs life span, promotes weight
gain, increases plasma hemoglobin levels, and provides tissues
with vitamin C and Mg (Khalil and El-Sheikh, 2010; Attia et al.,
2011). These virtues may be related to a complex of active
substances, including amino acids, vitamins like tocopherol,
niacin, thiamine, biotin, and folic acid, polyphenols, carotenoids,
phytosterols, and minerals (Denisow and Denisow-Pietrzyk,
2016).
Adverse Effects
Health risks linked to the use of bee pollen may derive
from the occasional presence of contaminants such as heavy
metals, pesticides, mycotoxins (e.g., ochratoxin A), and bacteria
(Denisow and Denisow-Pietrzyk, 2016). Moreover, bee pollen
derived from Echium vulgare, Symphytum officinale, and Senecio
jacobaea may contain dangerous levels of pyrrolizidine alkaloids
with hepatotoxic properties (Kempf et al., 2010).
As known, pollen is highly allergenic, and consequently,
complications or anaphylaxis due to bee pollen use have
been reported, making tests for individual sensitivity highly
recommendable before use (Jagdis and Sussman, 2012).
BEESWAX
Worker bees secrete beeswax by wax glands located in abdominal
segments. This substance is generally produced in greatest
amount during colony growth phase in late spring, and is
used for making combs. Beeswax is synthesized starting from
honey sugars, and has a crystalline structure suitable for hive
construction.
Chemical composition varies among bee species and
geographical zones, and includes hydrocarbons, of which major
ones are heptacosane, nonacosane, hentriacontane, pentacosane
and tricosane, free fatty acids and free fatty alcohols, linear
wax monoesters, hydroxymonoesters deriving from palmitic,
15-hydroxypalmitic, and oleic acids, and complex wax esters
containing 15-hydroxypalmitic acid and diols (Münstedt and
Bogdanov, 2009). A total of about 50 aroma components has
also been reported (Ferber and Nursten, 1977). The ester/acid
ratio is important for beeswax characterization by different
Pharmacopeias, being generally lower (3–4) in European,
and higher (8–9) in Asian beeswax (Münstedt and Bogdanov,
2009).
Beeswax is used as an additive in a variety of industrial
products and processes, such as food industry, candles, and
cosmetics. In pharmaceutical preparations it plays a role as a
thickener, binder, drug carrier and release retardant.
Antimicrobial Activity
Beeswax has been used since ancient times for its antimicrobial
properties in European and Asian traditional medicines.
Preservative effects are possibly at the basis of its use in
embalming and mummification practices by old Egyptians and
Persian, or to model death masks by ancient Romans.
A beeswax crude extract has shown inhibitory effects against
S. aureus, Salmonella enterica, C. albicans and Aspergillus niger
(Ghanem, 2011), while effects against pathogenic bacteria and
microscopic fungi have been reported for methanol and ethanol
extracts (Kacániová et al., 2012). This kind of effects could depend
at least in part on beeswax compounds of plant origin (Puleo and
Keunen, 1991).
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TABLE 1 | Reported effects for major compounds from different honeybee products.
Product Compound Effect Reference
Honey H2O2 Antimicrobial activity Brudzynski et al., 2011
MGO Antimicrobial activity Mavric et al., 2008
Defensin-1 Antimicrobial activity Kwakman and Zaat, 2012
Trihydroxyketone Apoptosis induction and p65, NF-KB and IL-6 repression in PC-3
cancer cells
Kassi et al., 2014
Royal Jelly MRJP-1 Block of mannose receptors in human phagocytic cells Molan and Rhodes, 2015
MRJP-1 Induction of TNF-α and MMP-9 in keratinocytes Majtan et al., 2010
MRJP-1 Increase of fecal bile acids and cholesterol excretion Kashima et al., 2014
MRJP-1 oligomer Promotion of Jurkat lymphoid cell proliferation Moriyama et al., 2015
MRJP-1 and MRJP-2 Stimulation of TNF-α release from macrophages Majtan et al., 2006
MRJP-3 Suppression of IL-2, IL-4, and IFN-γ production by
antigen-stimulated T cells
Okamoto et al., 2003
Apalbumin 2a (MRJP-2 variant) Antimicrobial activity Bilikova et al., 2009
Jelleins Antimicrobial activity Fontana et al., 2004
Royalisin Antimicrobial activity Bachanova et al., 2002
Royalactin Increase of lifespan in honeybees and other invertebrates Detienne et al., 2014
10-HDA Antimicrobial activity Alreshoodi and Sultanbawa, 2015
10-HDA Inhibition of LPS-induced NF-κB activation in murine macrophages Sugiyama et al., 2012
10-HDA Inhibition of histone deacetylase Makino et al., 2016
10-HDA Inhibition of synoviocytes from rheumatoid arthritis Wang et al., 2015
10-HDA Inhibition of IL-12 production by dendritic cells and of NO
production by macrophages
Sugiyama et al., 2013
10-HDA Modulation of dendritic cell, Th1 and Th2 activity Mihajlovic et al., 2013
10-HDA Increase of insulin-independent muscle glucose uptake Takikawa et al., 2013
10-HDA Improvement of hyperlipidemic condition in rats Xu et al., 2002
10-HDA Increase of longevity and oxidative stress tolerance in
Caenorhabditis elegans
Honda et al., 2015
10-HDA Increase of TGF-β1production and collagen synthesis in fibroblasts Park et al., 2011
10-HDA Inhibition of MMP-1 and MMP-3 release from rheumatoid arthritis
fibroblasts
Yang et al., 2010
10-HDA Prevention of UVA-induced JNK/p38 activation and MMP-1 and
MMP-3 upregulation in fibroblasts
Zheng et al., 2013
10-HDA and 10-hydroxydecanoic Inhibition of TRPA1 and TRPV1 receptors Terada et al., 2011
10-HDA Stimulation of neuron differentiation from rat embryo stem cells Hattori et al., 2007
3,10-dihydroxydecanoic acid Stimulation of dendritic cell differentiation Dzopalic et al., 2011
Sebacic acid Antifungal activity Melliou and Chinou, 2005
Propolis CAPE Inhibition of HIV-1 integrase Costi et al., 2004
CAPE Suppression of hepatitis C virus replication in vitro Zhang et al., 2003
CAPE Antigingivitis activity Li et al., 2017
CAPE Inhibition of IL-5 and IFN-γ production Wang et al., 2010
CAPE Inhibition of CD4+ T cell proliferation by targeting NF-κB and
AKT/PKB
Wang et al., 2010
CAPE Anti-inflammatory effect by targeting NF-κB Armutcu et al., 2015
CAPE Modulation of ERK in T cells and mastocytes Cho et al., 2014
CAPE Regulation of PI3K/AKT pathway in human cells Li et al., 2017
CAPE Suppression of tyr kinase activity and induction of cell cycle arrest Patel, 2016
CAPE Block of cancer cell migration and invasiveness Tseng et al., 2016
CAPE Voltage-gated sodium channel block in breast cancer cells Fraser et al., 2016
CAPE Selective inhibition of cancerous cell viability Kuo et al., 2015
Artepillin C Inhibition of CD4+ T cells, and of IL-2, IL-17, and IFN-γ release Wang et al., 2010
Artepillin C Antiproliferative effect on prostate cancer cells by targeting NF-κB Zhang et al., 2013
(Continued)
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TABLE 1 | Continued
Product Compound Effect Reference
Chrysin, galangin, CAPE, benzyl
ferulate, benzyl isoferulate, pinostrobin,
5-phenylpenta-2,4-dienoic acid, and
tectochrysin
Antiproliferative activity on different cancer cell lines Catchpole et al., 2015
Chrysin Antiproliferative effect on different cancer cells Patel, 2016
Chrysin TRAIL-induced caspase activation and STAT3 inhibition in
cancer cells
Lirdprapamongkol et al., 2013
Chrysin p38 and Bax activation in cancer cells Pichichero et al., 2011
Galangin, pinocembrin, and CAPE Inhibition of bacterial RNA polymerase Speciale et al., 2006
Galangin Proapoptotic effect on cancer cells Zhang et al., 2013
Pinobanksin Loss of mitochondrial membrane potential and caspase
activation in cancer cells
Alday et al., 2015
Pinobanksin-3-acetate Strong antioxidant effect Boisard et al., 2014
3,4-dicaffeoylquinic acid TRAIL upregulation and repression of influenza A virus in mice Takemura et al., 2012
Cardanol and cardol Antiproliferative effect on different cancer cells Teerasripreecha et al., 2012
Cardanol Induction of apoptosis in breast cancer cells with cyclin D
downregulation
Buahorm et al., 2015
Nemorosone Inhibition of MCF-7 cells by cell cycle block and of MAPK and
AKT
Popolo et al., 2011
Bee venom Melittin Cytotoxic effect by disruption of phospholipid bilayers Raghuraman and Chattopadhyay, 2007
Melittin Activation of TRPV receptors and release of algogens Chen et al., 2016
Melittin Anti-inflammatory effect Lee and Bae, 2016
Melittin Inhibition of PDGFR-β signaling Son et al., 2007
Melittin Antimicrobial effect Choi et al., 2015
Melittin Apoptosis induction in ovarian cancer cells by DR3, DR4, DR6
upregulation
Jo et al., 2012
Apamin Block of SK channels Castle et al., 1989
Apamin Antiatherosclerotic effect in mice Kim et al., 2012
PLA2 Allergenic effect Okano et al., 1999
PLA2 Treg activation in Parkinson’s mouse model Chung et al., 2015
PLA2 Activation of α2-adrenegic receptors in allodynia mouse model Li et al., 2015
Hyaluronidase Allergenic effect Padavattan et al., 2007
Bi-VSP serine protease Thrombin-like and plasmin-like fibrinolysis Choo et al., 2010
Secapin Serine protease inhibition and antimicrobial effect Lee et al., 2016
Inhibitor cysteine knot peptide and
Kazal-type serine protease inhibitor
Antimicrobial and insecticidal effects Park et al., 2014
Tertiapin Inward-rectifier K+ channel block Drici et al., 2000
MCD Mast cell degranulation and histamine release Buku, 1999
MCD Fast- and slow-inactivating K+ channel block Mourre et al., 1997
Bee Pollen Anethole NF-KB pathway inhibition Choi, 2007
MGO, methylglyoxal; MRJP, major royal jelly protein; 10-HDA, 10-hydroxy-2-decenoic acid; CAPE, caffeic acid phenethyl ester; PLA2, phospholipase A2; MCD, mast cell
degranulating peptide.
Dermatological and Cosmetic Properties
Beeswax has been known as a major Ayurvedic remedy for
inflammation, bruises, burns, and cracked heels (Gokani, 2014).
Ointments based on beeswax useful for joint pain, wounds and
burns, are reported in the Ebers Papyrus (about 3500 B.P.), by the
Greek-Roman physician Galen (about 2150 B.P.), and in old texts
of traditional Chinese medicine, such as the “Shen Nong Book of
Herbs” (about 2100–2200 B.P.) (Rit and Behrer, 1999).
Thanks to its very low irritant and comedogenic effects,
beeswax is widely used in modern cosmetics and makeup as a
thickener, emollient and emulsifier (Münstedt and Bogdanov,
2009).
FUTURE PERSPECTIVES
Pharmaceutical and clinical uses of honeybee products are
attracting increasing interest. Research and development in this
field generally concern whole materials or subfractions rather
than single compounds. Clinical trials have been conducted,
among others, with honey for cicatrization problems and
diabetes, with royal jelly for diabetes and rheumatoid arthritis,
with propolis for disinfection and gingivitis, and with bee
venom for Parkinsons’ and rheumatoid arthritis1. However, the
1https://clinicaltrials.gov
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complexity and variability in composition of these products raise
the need of their standardization before safe and predictable
clinical uses can be achieved.
Conversely, the use of specific compounds from honeybee
products as curative drugs has not been implemented yet. As
shown in the present review, various of these compounds have
been in-depth characterized for their effects on biochemical
pathways, cells, and organs, suggesting a series of possible
uses as therapeutic drugs (Table 1). Moreover, preclinical
studies indicate that some of these agents may be competitive
with standard drugs, possibly including MGO, MRJPs, jelleins,
royalisin, 10-HDA, CAPE, artepillin C, melittin, and apamin.
However, none of them is reported at the online clinical trial
database https://clinicaltrials.gov/, with the exception of CAPE2,
suggesting that their medicinal use as specific drugs is not
forthcoming.
Different reasons may explain the gap between the clinical
exploitation of whole honeybee products and their single
constituents. A role may be played in some cases by the toxicity
of the bioactive agent, or alternatively, by an economically
inefficient scale-up of pharmaceutical manufacturing, even
though some compounds can be obtained by synthetic way
too. Procedures for the chemical synthesis of MGO and CAPE
2 https://clinicaltrials.gov/ct2/show/NCT02744703?term=caffeic+acid&rank=3
have been patented, while synthetic MGO has been added in
some cases to medicinal honey for strengthening wound healing
properties (Wardell and Sabacinski, 2016). Methods for 10-HDA
purification from royal jelly, artepillin C from propolis, melittin
and apamin from bee venom, and their uses in pharmaceutical
preparations have been also patented (Iinuma et al., 2014).
Regardless whether the pharmaceutical exploitation of these
bioactives is going to take off or not, studies aimed at refining
the knowledge of their mechanisms of action remain of pivotal
importance for developing applications of honeybee products to
medicinal uses.
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